The bacterial aetiology of pleural empyema. A descriptive and comparative metagenomic study by Dyrhovden, Ruben et al.
lable at ScienceDirect
Clinical Microbiology and Infection 25 (2019) 981e986Contents lists avaiClinical Microbiology and Infection
journal homepage: www.cl inicalmicrobiologyandinfect ion.comOriginal articleThe bacterial aetiology of pleural empyema. A descriptive and
comparative metagenomic study
R. Dyrhovden 1, *, R.M. Nygaard 1, R. Patel 2, 3, E. Ulvestad 1, 4, Ø. Kommedal 1
1) Department of Microbiology, Haukeland University Hospital, Bergen, Norway
2) Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester MN, USA
3) Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester MN, USA
4) Department of Clinical Science, University of Bergen, Bergen, Norwaya r t i c l e i n f o
Article history:
Received 28 August 2018
Received in revised form
15 November 2018
Accepted 30 November 2018
Available online 21 December 2018







RpoB* Corresponding author. R. Dyrhovden, Departmen
University Hospital, Jonas Lies vei 65, 5021 Bergen, N
E-mail address: ruben.dyrhovden@helse-bergen.n
https://doi.org/10.1016/j.cmi.2018.11.030
1198-743X/© 2018 The Author(s). Published by Elsevie
the CC BY-NC-ND license (http://creativecommons.ora b s t r a c t
Objectives: The view of pleural empyema as a complication of bacterial pneumonia is changing because
many patients lack evidence of underlying pneumonia. To further our understanding of pathophysio-
logical mechanisms, we conducted in-depth microbiological characterization of empyemas in clinically
well-characterized patients and investigated observed microbial parallels between pleural empyemas
and brain abscesses.
Methods: Culture-positive and/or 16S rRNA gene PCR-positive pleural fluids were analysed using massive
parallel sequencing of the 16S rRNA and rpoB genes. Clinical details were evaluated by medical record
review. Comparative analysis with brain abscesses was performed using metagenomic data from a na-
tional Norwegian study.
Results: Sixty-four individuals with empyema were included. Thirty-seven had a well-defined microbial
aetiology, while 27, all of whom had community-acquired infections, did not. In the latter subset,
Fusobacterium nucleatum and/or Streptococcus intermedius was detected in 26 patients, of which 18 had
additional facultative and/or anaerobic species in various combinations. For this group, there was 65.5%
species overlap with brain abscesses; predisposing factors included dental infection, minor chest trauma,
chronic obstructive pulmonary disease, drug abuse, alcoholism and diabetes mellitus. Altogether,
massive parallel sequencing yielded 385 bacterial detections, whereas culture detected 38 (10%) and 16S
rRNA gene PCR/Sanger-based sequencing detected 87 (23%).
Conclusions: A subgroup of pleural empyema appears to be caused by a set of bacteria not normally
considered to be involved in pneumonia. Such empyemas appear to have a similar microbial profile to
oral/sinus-derived brain abscesses, supporting spread from the oral cavity, potentially haematogenously.
We suggest reserving the term ‘primary empyema’ for these infections. R. Dyrhovden, Clin Microbiol
Infect 2019;25:981
© 2018 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology
and Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Empyema, defined as the presence of bacteria or pus in the
pleural cavity, is a serious infection with high morbidity and mor-
tality (15%e20%) and increasing incidence [1]. Predisposing con-
ditions include bacterial pneumonia, surgery, trauma, oesophageal
perforation, thoracentesis, subdiaphragmatic infection, sponta-
neous pneumothorax and septicaemia [2]. Traditionally, thet of Microbiology, Haukeland
orway.
o (R. Dyrhovden).
r Ltd on behalf of European Society
g/licenses/by-nc-nd/4.0/).predominant cause has been assumed to be bacterial pneumonia in
which bacteria breach the visceral pleura to establish an infected
parapneumonic effusion [1,2]. This concept has recently been
challenged. Differences between the typical bacteriology of pneu-
monia and empyema have been highlighted, with many patients
with empyema having no evidence of an underlying pneumonia
[1,3,4]. Such observations suggest that pleural empyema and
pneumonia should, in some cases, be considered separate condi-
tions [1,3e5], anddfurthermoredthat the mechanisms and sour-
ces of bacterial invasion of the pleural cavity are poorly understood
[1,4,5].of Clinical Microbiology and Infectious Diseases. This is an open access article under
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targeted 16S rRNA gene-based metagenomics on brain abscesses
[6]. Three bacterial species (Streptococcus intermedius, Fusobacte-
rium nucleatum and Aggregatibacter aphrophilus) were either sole
pathogens or a dominant part of abscesses with an assumed oral or
sinus origin. This led us to hypothesize that these three microbes
may be involved in initial establishment of these infections, with
the additional species detected representing later colonizers.
In our routine clinical practice, we more recently observed that
many pleural empyema samples have a microbiome similar to that
of brain abscesses. This suggested a new hypothesis that a small
group of highly specialized bacteria in the oral cavity may, under
appropriate conditions, spread to and establish purulent infections
in highly oxygenated organs, including the brain and lung.
The aim of the present investigation was to conduct a thorough
bacterial characterization of pleural empyemas from clinically well-
characterized patients to further our understanding of patho-
physiological mechanisms. This endeavour included a comparison
between pleural empyemas and brain abscesses.
Materials and methods
We conducted a retrospective study at the Department of
Microbiology, Haukeland University Hospital, Bergen, Norway. The
study was approved by the regional ethical committee (2017/1095).
Study definition of pleural empyema
Pleural empyema was defined as the presence of bacteria in
pleural fluid by Gram stain, culture or 16S rRNA gene PCR [1]. Since
previous studies have not included detection of bacterial DNA in
their definitions, all patients were also evaluated according to the
traditional criteria for pleural empyema, defined as a positive Gram
stain or bacterial culture of pleural fluid or macroscopic purulent
pleural fluid or pleural pH < 7.2 combined with clinical evidence of
infection [1,3,7].
Clinical samples
The Department covers a population of ~500 000 people and
also receives occasional samples from other regional hospitals.
Upon clinical suspicion of infection, the laboratory routinely per-
forms partial amplification and Sanger-based sequencing of a
portion of the bacterial 16S rRNA genes directly from pleural fluid
(see Supplementary material, Document S1). For the present
investigation, we searched the laboratory information system for
culture-positive and/or 16S rRNA gene PCR-positive pleural fluid
samples obtained from patients >17 years of age, admitted from
January 2016 through to December 2017. Remnant extracted DNA
from these samples was collected from a Biobank for targeted
metagenomic analysis. Samples from 64 unique patients were
eligible for inclusion. Eighteen patients with culture-positive em-
pyemas could not be included because 16S rRNA gene PCR had not
been performed and no extracted DNA was available (see Supple-
mentary material, Table S1). Pleural fluids from 11 patients with a
low suspicion of infection, negative cultures and negative 16S rRNA
gene PCR were included as a negative patient control group.
Clinical definition of pneumonia
Pneumonia was defined by fulfilment of the following criteria:
(i) at least two of the following: fever, cough, sputum productionand/or chest pain; and (ii) radiographic evidence of pneumonia, as
interpreted by a radiologist [7].
Massive parallel sequencing of partial 16S rRNA and rpoB genes
Massive parallel sequencing was performed using the MiSeq
system (Illumina, Redwood City, CA, USA). Some clinically impor-
tant bacterial families and genera display too few variations in the
16S rRNA gene to reliably identify them to the species level [8].
Therefore, for selected groups of bacteria, we supplemented the
analysis with massive parallel sequencing of parts of rpoB [9],
which is more discriminatory than the 16S rRNA gene.
A detailed protocol for sequencing of all targets, including
primers, description of negative controls, management of back-
ground DNA and sequence data analysis can be found in the Sup-
plementary material (Document S1). For novel undescribed species
we used the provisional HMT-taxonomy [10].
Statistical analysis
Statistical analysis was performed using SPSS 25 (IBM Corp).
Differences between subgroups were analysed with Pearson's chi-
squared test. Microbial b-diversity analysis for the empyemas,
including unweighted and weighted UniFrac metrics [11,12], was
performed in QIIME2. Comparison between a subset of the data
from this study and previous data from the Norwegian brain ab-
scess study [6], was undertaken using UniFrac and Principal Coor-
dinate Analysis in QIIME2. EMPeror [13] was used to visualize
Principal Coordinate Analysis plots. Venn-diagram analysis was
performed using the web tool http://bioinformatics.psb.ugent.be/
webtools/Venn/. For the Venn-diagram analysis, we included spe-
cies that were found in at least two cases in one of the two groups.
Results
Description of study population
The mean age of the 64 patients was 62 years (median 68, range
18e93). Fifty (78%) patients were male. Twenty-one (32%) had no
history of smoking, while 24 (38%) were current smokers and 19
(30%) were former smokers. The most frequent chronic diseases
were hypertension (15 patients, 23%) and chronic obstructive pul-
monary disease (11 patients, 17%). Nineteen patients (30%) had no
chronic disease. Sixty (94%) patients fulfilled the traditional criteria
[1,3,7] for pleural empyema. The four patients who did not (Patients
5, 28, 47 and 62) included two postoperative infections, one Fran-
cisella tularensis infection and one infection of poorly described
aetiology.
Technical sequencing data
After removal of short reads (<250 base pairs), small clusters
(<20 reads) and chimeras, the mean number of valid reads was
75 426 per sample (range 19 892 to 311 160, median 65 286).
Microbiological findings and correlations with clinical data
Out of 385 bacterial detections made by massive parallel
sequencing, culture detected only 38 (10%) and Sanger-based 16S
rRNA gene sequencing detected 87 (22.5%) (see Supplementary
material, Table S2). Thirty-nine (61%) of the 16S rRNA gene PCR-
positive samples were culture-negative. None of the 11 samples
Table 2
Demographic and clinical characteristics of empyemas with poorly described aeti-
ology (PDE) versus those occurring after classic community-acquired pneumoniaa
(CAP)
PDE CAP p-valueb
Number of patients 27 10
Male, n 24 5 0.01
Mean age, years (SD) 56 (18) 65 (18) 0.17
Smoker, n 11 4 0.97
Fever, n 21 8 0.88
Chest pain, n 25 5 0.003
Dyspnoea, n 24 9 0.92
Cough, n 18 8 0.43
Purulent sputum, n 8 3 0.98
Mean CRPc (SD) 230 (107) 313 (83) 0.03
Mean leucocytesd (SD) 19.3 (8.2) 21.0 (11.8) 0.60
Purulent pleural fluid, n 19 9 0.21
Mean pH of pleural fluid (SD) 7.0 (0.6) 7.1 (0.3) 0.69
Mean glucosee (SD) 2.2 (2.8) 1.0 (2.2) 0.41
Intensive care, nf 2 2 0.27
Death, ng 0 1 0.10
a Fulfilment of diagnostic criteria for CAP and identification of bacteria known to
cause CAP: Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aerugi-
nosa and Streptococcus pyogenes.
b Pearson's chi-squared test for categorical variables. Students t-test for contin-
uous variables.
c C-reactive protein (mg/L) at admission.
d Leucocytes (109/L) at admission.
e Mean glucose level (mmol/L) in pleural fluid.
f Admitted to intensive care unit during the hospital stay.
g Death during the hospital stay.
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beyond that found in the negative controls.
By 16S rRNA and rpoB gene massive parallel sequencing, bac-
teria from 183 species were identified, of which 157 could be
assigned to the species level, 13 to a species group level, and 8 to a
genus level. Five Operational taxonomic units yielded no significant
match with published sequences. rpoB sequencing was performed
for 44 samples (69%) and provided identification at a higher taxo-
nomic level than 16S rRNA gene sequencing for 25 species (see
Supplementary material, Table S3).
Thirty-seven patients had a well-defined aetiology underlying
their pleural fluid infection (Table 1). Among thesewere 19 patients
with monomicrobial infections caused by Streptococcus pneumo-
niae (8), Staphylococcus aureus (5), Pseudomonas aeruginosa (2),
Streptococcus pyogenes (1), Escherichia coli (1), Klebsiella pneumo-
niae (1) or Francisella tularensis (1). Streptococcus pneumoniae was
identified exclusively in monomicrobial samples, including seven
cases of community-acquired pneumonia (CAP) and one case of
postoperative empyema after lung resection. All identifications of
Staphylococcus aureus and Streptococcus pyogenes were also made
in monomicrobial samples, except for one patient with CAP who
had a mixed infection with the two species. Empyemas resulting
from surgical complications or spontaneous rupture of the
oesophagus presented the highest microbial diversity. An overview
of clinical data and identified microbes in each of these 37 in-
dividuals is provided in the Supplementary material (Table S4).
For the remaining 27 patients, the aetiology was less obvious.
The Supplementary material (Table S5) summarizes the clinical
history, computed tomography findings and identified bacteria in
these individuals. All 27 infections were community-acquired.
Several potential predisposing factors were identified. Six pa-
tients reported a minor blunt chest trauma before the onset of
symptoms (such as blunt violence or fall accidents) and five of six
patients in whom dental status was addressed had poor dental
health. Other lung-related pathology among patients included
chronic obstructive pulmonary disease (4) and computed
tomography-diagnosed lung abscess (3). Only 12 out of 27 fulfilled
the diagnostic criteria for CAP and all patients were negative for
CAP-associated bacteria. Other possible predisposing co-
morbidities were drug abuse (4), alcoholism (3) and diabetes
mellitus (3). Table 2 provides a comparison of demographics and
clinical features between the 27 patients with empyema with
poorly described aetiology versus the ten patients with classic post-
pneumonia empyema.
In both the weighted and unweighted UniFrac analyses, most of
the 27 samples with uncertain aetiology clustered in neighbouringTable 1
Patients with well-defined aetiologies of empyema
Postoperativea 12
Community-acquired pneumoniab 10
Metastatic cancer affecting the lung 4
Sepsis 4
Spontaneous rupture of the oesophagus 2
Hospital-acquired pneumonia 2
Lemierre syndrome 1
Francisella tularensis pneumonia 1
Post-traumatic 1
Sum 37
a Includes five cases occurring after upper gastrointestinal tract surgery, four
cases after heart and lung surgery, and three cases after abdominal surgery.
b Fulfilment of diagnostic criteria for community-acquired pneumonia (CAP) and
identification of bacteria known to cause CAP (Streptococcus pneumoniae (7),
Streptococcus pyogenes (1), Pseudomonas aeruginosa (1), Staphylococcus aureus and
S. pyogenes (1)).branches, indicating significant similarities in microbial patterns
(Fig. 1). Though they contained many of the species found in
oesophageal ruptures and postoperative infections, they were
distinguished from these by having lower microbial diversity and
higher inter-sample consistency, both quantitatively and qualita-
tively. In total, they harboured 54 different species, of which 33
were identified in single patients. Among the 21 species found in
multiple samples, Streptococcus intermedius and Fusobacterium
nucleatum stood out both as being the most frequent bacteria
detected on a patient-level and as being among the most abundant.
Twenty-six (96%) of the 27 samples contained either Streptococcus
intermedius (n¼ 9) or F. nucleatum (n¼ 10), or a combination of the
two (n¼ 7). Streptococcus intermediuswas the only detected species
in eight samples, whereas F. nucleatum was detected alone in two.
The single sample without either Streptococcus intermedius or
F. nucleatum was a monomicrobial infection caused by
A. aphrophilus in a patient with pulmonary sarcoidosis.
The microbial patterns observed in the empyema cases of un-
certain aetiology had similarities with oral-type bacterial brain
abscesses; Fig. 2 is a Venn diagram analysis for both infection types
showing 19 (65.5%) shared species. The most frequent common
species were F. nucleatum, Streptococcus intermedius, Parvimonas
micra and Eubacterium brachy, all present in more than 30% of
samples from both infection types. Themost notable differencewas
observed for A. aphrophilus, found in 40% of brain abscesses but
only in a single empyema (3.7%). In a comparative analysis of the
two specimen types, Principal Coordinates Analysis plots based on
UniFrac metrics showed no clear clustering into separate groups
(Fig. 3).
Discussion
In this study, we provide a clinical and microbiological charac-
terization of 64 patients with empyema. To the best of our
knowledge, this is the first investigation in which such a large
Fig. 1. UniFrac-analysis of empyemas. Phylogenetic tree of unweighted (a) and
weighted (b) UniFrac-analysis of all included pleural empyemas. Each number repre-
sents one sample. CAP, fulfilment of diagnostic criteria for community-acquired
pneumonia (CAP) and identification of bacteria known to cause CAP: Streptococcus
pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus
pyogenes.
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geted metagenomics analysis.
We identified a subgroup of 27 patients with community-
acquired infections with unclear explanation as to how the bac-
teria had reached the pleural cavity. All empyemas harbored oral
bacteria not normally associated with pneumonia, and shared
distinct microbial patterns overlapping with those previously
described for oral/sinus-type brain abscesses. Samples from 26 of
27 patients contained either Streptococcus intermedius or
F. nucleatum or a combination of the two, and these were also,
together with A. aphrophilus, the only bacteria detected in mon-
omicrobial infections. We therefore hypothesize that F. nucleatum
and Streptococcus intermedius are possible key pathogens for
establishing these empyemas, much like previously suggested for
bacterial brain abscesses [6]. Aggregatibacter aphrophilus, found in
a single monomicrobial empyema, does not seem to be very
common in pleural empyemas, though it was found in 40% of brain
abscesses.Fusobacterium nucleatum was found in all empyemas harbour-
ing strict anaerobic bacteria, except for one containing Fusobacte-
rium gonidiaformans. Although traditionally thought of as a strict
anaerobe, F. nucleatum is a moderate anaerobe with capacity for
oxygen adaption [14,15]. In periodontitis research, it is considered a
key organism in the transition between early facultative colonizers
and later obligate anaerobes [16].
In patients with pneumonia, pathogens may overcome pulmo-
nary defence mechanisms and reach the pleural cavity by direct
transpleural spread from the respiratory alveoli. The capacity of
Streptococcus pneumoniae to do this is well-described [1], but for
Streptococcus intermedius and F. nucleatum, we have found no evi-
dence of a similar ability. For anaerobic bacteria this mode of
dissemination would be halted by the high oxygen tension in the
respiratory tract. When examining the clinical characteristics for
the 27 patients with empyemas of uncertain pathogenesis, only 12
had possible pneumonia. However, since diagnostic criteria for CAP
are based on clinical features with low diagnostic specificity and
sensitivity [7,17] and display considerable overlap with the most
common signs and symptoms of pleural empyema, we believe the
actual number of pneumonias may have been even lower than
reported [7].
For brain abscesses, an important route of infection is
dissemination of bacteria via the haematogenous route from
primary sinusitis or an odontogenic focus [18e20]. Bacteria are
thought to reach the brain parenchyma by transit trough valve-
less emissary and diploic veins that drain through the skull bone
and into the venous system of the brain [19]. This mode of
transmission is supported by the observation that abscesses
formed by oral pathogens are the dominant type of abscess in all
regions of the brain, not just in the frontal lobe [6]. The lung
parenchyma and the visceral pleura are therefore natural sites
along the same route of infection. Infected venous blood follows
the venous draining system to the right ventricle of the heart and
is pumped into the pulmonary arteries, ending up in the capillary
network of alveoli and parts of the visceral pleura. Indeed, several
studies and case reports describe the simultaneous occurrence of
brain abscess and lung abscess or pleural empyema [21e24], both
in general and for F. nucleatum and Streptococcus intermedius,
specifically.
We therefore suggest, based on the findings in this study, that
facultative and anaerobic oral bacteria, able to spread via deoxy-
genated venous blood to establish purulent infections in brain tis-
sue, are also capable of reaching and establishing pyogenic
infections in the lung parenchyma or pleural cavity, and that right-
sided haematogenous spread is a plausible route of infection in
oral-type bacterial pleural empyema.
We found a remarkably high involvement of males in oral-type
bacterial empyema that significantly differed from the even gender
distribution of classic post-pneumonia empyema (Table 2). The
same uneven gender distribution has been observed in other
studies on pleural empyema, and specifically among those caused
by the Streptococcus anginosus group [25e27]. Odontogenic in-
fections have been identified as a potential risk factor for pleural
empyema [27] and one explanation of the male predominance
might be a higher frequency of serious odontogenic infections in
men [28]. Except for dental caries, we found the most common co-
morbidities to be hypertension, chronic obstructive pulmonary
disease, injection drug use, alcoholism and diabetes mellitus (see
Supplementary material, Table S5). This correlates with findings
from previous studies [27,29]. Male gender, odontogenic infections
and injection drug use are also definite risk factors for brain ab-
scesses [19,20]. Another finding that might represent a hitherto
unappreciated predisposing factor, is that six patients had a history
of a minor blunt chest trauma just before symptom onset. In brain
Fig. 2. Venn diagram analysis comparing species found in 27 empyemas of poorly described aetiology and 25 brain abscesses with assumed oral/sinus origin. The numbers in
parenthesis are the total number of species found in each group. In the middle column, the first number in parenthesis represents empyemas and the second brain abscesses.
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presence of ischaemic or devitalized brain tissue occurring after
incidents such as trauma or cerebrovascular accidents [20]. Blunt
chest trauma may cause damage to the visceral pleura or adjacent
lung parenchyma, leading to the formation of a poorer oxygenated
locus minores resistentiae (e.g. a haematoma or atelectasis) facili-
tating colonization by blood-borne oral microbes.
The retrospective design is a weakness of our study; 18
culture-positive samples were lost due to lack of sample avail-
ability (see Supplementary material, Table S1). Information about
dental status was available from only six patients, and informa-
tion about preceding minor trauma was not systematically
collected. Another limitation is that this is a case study from one
particular area of the world. The oral microbiome varies between
geographical areas [30] and this may influence the bacterial
composition of pleural empyema as well. The findings andhypotheses proposed in this article should clearly be challenged
in future, prospective studies.
We have shown that a large subgroup of community-acquired
pleural empyemas is caused by a limited set of oral bacteria not
normally involved in pneumonia. We provide microbiological,
anatomical and epidemiological arguments to support that these
pleural empyemas and oral/sinus-derived brain abscesses might be
two sides of the same coin sharing microbial composition, haema-
togenous routes of infection and risk factors. We suggest that the
term ‘primary empyema’ should be reserved for this type of infection
to distinguish it from pleural empyema secondary to other lung
conditions, including classic post-pneumonia empyema and post-
operative empyema. Our finding also suggest that traditional
culture-based methods and even Sanger-based 16S rRNA gene PCR/
sequencing may be insufficient in characterizing the microbial
spectrum of primary empyemas.
Fig. 3. Comparative UniFrac-analysis of empyemas and brain abscesses. Principal Co-
ordinates Analysis of unweighted (a) and weighted (b) UniFrac-analysis of the 27
empyemas of poorly described aetiology and 25 oral/sinus-derived brain abscesses.
The figure shows no clear clustering into separate groups. Each dot represents one
sample.
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